Project Grant HT94252411092
Award Date 9/15/24
Completion Date 9/14/27
Dollars Obligated $1.6M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
- The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
- This Project Grant award for $1,202,462, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "Clinical Translation of Fast-Curable Corneal Glue for Corneal Penetrating Injuries" at the University of Illinois in Chicago. The funding will enable the development and testing of an innovative corneal glue to aid the treatment of penetrating eye injuries, which is a critical medical need for military personnel and...
- The Schepens Eye Research Institute, Inc. was awarded a $1,475,676 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop concomitant topical treatments for pain and inflammation resulting from ocular injuries. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
- This federal Project Grant award, valued at $1,593,795.00 and awarded on July 15, 2025, supports the "Exploration of Topical Amniotic Membrane of the Treatment of Ocular Chemical and Thermal Burn Injuries" research project. The grant was awarded by the Defense Health Agency, which administers the Military Medical Research and Development program (CFDA 12.420). The research is being conducted by the University of Illinois, a prominent public research institution in Chicago, Illinois....
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,477,500 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The 3-year grant, awarded on September 1, 2023, will fund research on "Topical Calcitonin Gene-Related Peptide for Corneal Injury Prevention and Regeneration." The Schepens Eye Research Institute, which has...
- The Defense Health Agency awarded a $1,061,440 Project Grant to the University of South Florida (USF) on September 1, 2023 under the Military Medical Research and Development (CFDA 12.420) program. This 3-year grant will support USF's development of an artificial cornea and sensor-based continuous intraocular pressure (IOP) monitoring system to treat patients with cornea blindness secondary to war-related ocular injuries. The products and services to be delivered through this grant include...
- This $1,200,000.00 federal Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the development of a 3D-fabricated controlled-release drug delivery system to stimulate scarless corneal wound healing at Baylor College of Medicine in Houston, TX. The research project aims to advance innovative medical technologies that can transform healthcare for military service members and the broader public. The...
- This $1,003,539.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports AI-based screening of ultra-large chemical libraries to identify selective muscarinic receptor antagonists as potential therapeutics for peripheral neuropathy. The research, which will be conducted from April 1, 2025 to March 31, 2028, aims to...
- This federal Project Grant award, valued at $319,151.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on a novel miR-155 therapy for the treatment of peripheral neuropathy. The project aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and...
- This $2,199,936 project grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a point-of-care, scalable, long-acting nanoparticle anesthetic tilapia dressing for burn wound and pain management. The University of California, Davis is the primary awardee and will conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The project aims to develop...